Best selling and fastest growing drugs in the 2nd quarter of 2020

Best selling drugs Once more Humira┬« from AbbVie is the best selling drug of the quarter ($4,837M) despite headwinds in Europe from biosimilars Amgevita┬«, Amsparity┬«, Halimatoz┬«, Hefiya┬«, Hulio┬«, Hyrimoz┬«, Idacio┬« and Imraldi┬«. In the US Humira┬« will in 2023 lose market exclusivity to the biosimilars Amjevita┬«, Cyltezo┬«, Hyrimoz┬«, Hadlima┬«, Abrilada┬« and Hulio┬«. AbbVie upon acquisition …